PRPS2 and cancer: Strikingly, PRPS2 is specifically upregulated to enhance nucleotide and protein biosynthesis in cancer cells with oncogene c-Myc overexpression, and the knockout of PRPS2 is synthetically lethal to such cancer cells30–34.